Cargando…
216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342303/ https://www.ncbi.nlm.nih.gov/pubmed/26876256 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.01.012 |
| _version_ | 1783555439030435840 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7342303 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73423032020-07-16 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2016-01 /pmc/articles/PMC7342303/ /pubmed/26876256 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.01.012 Text en 2016年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
| spellingShingle | 短篇论著 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 |
| title | 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 |
| title_full | 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 |
| title_fullStr | 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 |
| title_full_unstemmed | 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 |
| title_short | 216例惰性B细胞淋巴瘤患者临床特征及治疗预后分析 |
| title_sort | 216例惰性b细胞淋巴瘤患者临床特征及治疗预后分析 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342303/ https://www.ncbi.nlm.nih.gov/pubmed/26876256 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.01.012 |
| work_keys_str_mv | AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī AT 216lìduòxìngbxìbāolínbāliúhuànzhělínchuángtèzhēngjízhìliáoyùhòufēnxī |